Tenaya Therapeutics logo

Tenaya Therapeutics

TNYA | NASDAQ
Chart Builder DCF Calculator
$0.39
-$0.13 (-25.14%)
At close: Oct 14, 2026, 4:00 PM ET
-25.14%

Rating

Updated: Oct 3, 2026
48
+19.5 pts
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $84.74M
1D Range
0.36 0.51
52W Range
0.36 2.04

Valuation (TTM)

PE -0.74
PB 1.22
EV/EBITDA -0.11

Valuation (NTM)

Forward PE 10.73
Forward PEG 0.05
Price Target $2.33
Loading financial charts...

Profile

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gen...

Sector Healthcare
Industry Biotechnology
Employees 70
IPO Date Jul 30, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$2.00
Upside
+412.82%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.